Biased IL2 muteins methods and compositions
Abstract:
The present disclosures related to human interleukin-2 (hIL2) muteins, pharmaceutical formulations thereof, methods for preparing interleukin-2 muteins, recombinant vectors and cells comprising nucleic acids encoding IL2 muteins and methods for the treatment of human disease.
Public/Granted literature
Information query
Patent Agency Ranking
0/0